SCIENCE 37

Reports & White Papers

 
SCIENCE 37

Reports & White Papers

 
Factsheet
Download the Science 37 Solutions Fact Sheet
Science 37 Solutions Fact Sheet
Science 37 offers a comprehensive suite of solutions that are transforming the landscape of clinical research, providing unprecedented access, efficiency, and patient-centricity.…
Read More
/Resources/science-37-solutions-fact-sheet
Factsheet
Science 37 Patient Recruitment
Science 37 Patient Recruitment
Central patient recruitment campaigns have proven helpful in accelerating enrollment, but the overwhelming majority of participant referrals never make it to the first office visit…
Learn More
/Resources/science-37-patient-recruitment
Playbook
Download the Playbook on How to Operationalize Neurology Clinical Trials with the Metasite™
How to Operationalize Neurology Clinical Trials with the Metasite™
With a virtual site, clinical trial sponsors and research organizations can expand access and accelerate recruitment by allowing patients to participate from anywhere, regardless of…
Read More
/Resources/how-operationalize-neurology-clinical-trials-metasitetm
Playbook
How to Operationalize Respiratory Clinical Trials with the Metasite™
How to Operationalize Respiratory Clinical Trials with the Metasite™
Are you looking to expand patient access for your respiratory clinical trials? Discover how a virtual site solution allows patients to enroll and participate in trials from anywhere,…
Read More
/Resources/how-operationalize-respiratory-clinical-trials-metasitetm
White Paper
A Survey-Based Exploration of Biopharma's Shifting Landscape and the Crucial Role of Direct-to-Patient Trials
A Survey-Based Exploration of Biopharma's Shifting Landscape and the Crucial Role of Direct-to-Patient Trials
In the ever-changing landscape of clinical research, transformation is driven by forces of economic challenges, increasingly slender budgets, and the persistent hurdle of patient…
Read More
/Resources/survey-based-exploration-biopharmas-shifting-landscape-and-crucial-role-direct-patient
Playbook
How to Operationalize Cardiology Clinical Trials with a Metasite™
How to Operationalize Cardiology Clinical Trials with a Metasite™
Virtual sites (like the Science 37 Metasite™) are a patient-friendly decentralized clinical trial (DCT) model that enables expansive trial access and can support a…
Read More
/Resources/how-operationalize-cardiology-clinical-trials-metasitetm
Published Paper
eCOA Systems and Intended Use: Key Considerations
eCOA Systems and Intended Use: Key Considerations
Science 37 VP of Global Product Development, Lisa Charlton, and other experts from the Critical Path Institute Consortium provided important considerations when interpreting data…
Read More
https://www.appliedclinicaltrialsonline.com/view/ecoa-systems-and-intended-use-key-considerations
Published Paper
More than Just Rules: Raising the Bar in GCP Adherence
More than Just Rules: Raising the Bar in GCP Adherence
Science 37 Chief Medical Officer, Dr. Jonathan Cotilar, spoke with Applied Clinical Trials about training operations at Science 37, sharing how training happens regularly at various…
Read More
https://www.appliedclinicaltrialsonline.com/view/more-than-just-rules-raising-the-bar-in-gcp-adherence
Playbook
How to Operationalize Psychiatry Trials with the Science 37 Metasite™
How to Operationalize Psychiatry Trials with the Science 37 Metasite™
Driven by the Metasite, Science 37 is at the forefront of delivering accessible and patient-friendly decentralized clinical trials (DCT) and is leading the delivery of standard…
Learn More
/Resources/how-operationalize-psychiatry-trials-science-37-metasitetm
Report
Science 37 Receives the 2023 Frost & Sullivan Market Leadership Award
Science 37 Receives the 2023 Frost & Sullivan Market Leadership Award
Science 37 has been recognized with the prestigious Frost & Sullivan Market Leadership Award in the global decentralized clinical trials (DCT) industry. This acknowledgment…
Read More
/market-leader-award
Published Paper
FDA’s Landmark Guidance on Decentralized Clinical Trials (DCTs) Signals a New Era of Patient-Centered Research
FDA’s Landmark Guidance on Decentralized Clinical Trials (DCTs) Signals a New Era of Patient-Centered Research
In this paper, published in MedCity News, Science 37 Chief Medical Officer Dr. Jonathan Cotliar explores the FDA Draft Guidance on decentralized clinical trials (DCTs). With…
Read Now
https://medcitynews.com/2023/05/fdas-landmark-guidance-on-decentralized-clinical-trials-dcts-signals-a-new-era-of-patient-centered-research/
Insight Brief
New FDA Draft Guidance Shows That the Time for Decentralized Clinical Trials is Now
New FDA Draft Guidance Shows That the Time for Decentralized Clinical Trials is Now
On May 1, 2023, the U.S. Food and Drug Administration (FDA) released an updated Draft Guidance on decentralized trials, providing recommendations for clinical trial sponsors as they…
Learn More
/Resources/new-fda-draft-guidance-shows-time-decentralized-clinical-trials-now
Playbook
Transform RWE Studies with Virtual Approaches
Transform Real-World Evidence (RWE) Studies with Virtual Approaches
Increased adoption of mobile devices, wearables, and other biosensor technologies has created a wealth of real-world data (RWD) sources for clinical trial sponsors to leverage for both…
Learn More
/Resources/transform-rwe-studies-virtual-approaches
Insight Brief
Transform Observational Studies with a Virtual Site.
Transform Observational Studies with a Virtual Site
Are your observational or long-term follow-up studies facing challenges? Are keeping protocols open across multiple sites slowing down your studies? Or is loss of participant…
Read More
/Resources/transform-observational-studies-virtual-site
Playbook
How Science 37 Partners with Contract Research Organizations
How Science 37 Partners with Contract Research Organizations
As the pioneer in virtual clinical trials, Science 37 offers contract research organizations (CROs) the most experience and ability to accelerate study timelines.  Through in-…
Read More
/Resources/how-science-37-partners-contract-research-organizations
Playbook
How to Operationalize Dermatology Clinical Trials with a Virtual Site.
How to Operationalize Dermatology Clinical Trials with a Virtual Site
Clinical trials for dermatology can be a uniquely challenging endeavor for sponsors and clinical researchers, as it is challenging to identify and support patients who have not…
Read More
/Resources/how-operationalize-dermatology-clinical-trials-virtual-site
Factsheet
The Science 37 Metasite™
The Science 37 Metasite™
Science 37's mission is to accelerate clinical research by enabling universal trial access for patients. As a single Metasite, we reach an expanded patient population beyond the…
Learn More
/Resources/science-37-metasitetm
Insight Brief
How to Save an At-Risk Clinical Trial
How to Save an At-Risk Clinical Trial
How can you rescue an at-risk clinical trial without compromising quality? Delays in clinical research are common and cost pharmaceutical companies exorbitant amounts of money. Four in…
Read More
/Resources/how-save-risk-clinical-trial
Playbook
THE INFECTIOUS DISEASE CLINICAL TRIAL PLAYBOOK
How to Operationalize Infectious Disease Trials with a Virtual Site
Download our Infectious Disease Clinical Trial Playbook to discover the premier, patient-centric strategy for solving hallmark challenges in infectious disease research. In this…
Learn More
/Resources/how-operationalize-infectious-disease-trials-virtual-site
Infographic
Oncology Survey Infographic
Clinical Decision Makers Confirm a Shift to Hybrid and Decentralized Studies
Clinical research is undergoing transformation across the board—but how will it impact oncology clinical trials? Science 37® has surveyed research executives at trial-sponsored…
Read More
Science37_OncologySurvey_Infographic_112822.pdf
/Resources/clinical-decision-makers-confirm-shift-hybrid-and-decentralized-studies
Playbook
Operationalize Oncology Trials
How to Operationalize Oncology Trials with a Decentralized Approach
The importance of oncology in pharmaceutical research cannot be underestimated. However, oncology trials face challenges such as slow recruitment, complex protocols and frequent…
Read Now
/Resources/how-operationalize-oncology-trials-decentralized-approach
White Paper
Decentralized Clinical Trials — Is there a Positive Return on Investment on a Virtual Site?
Decentralized Clinical Trials — Is There a Positive Return on Investment on a Virtual Site?
Across the Life Sciences industry, there has been much talk about the cost and value of decentralized clinical trials (DCT) and the potential return on investment (ROI)  when the…
Read Now
/Resources/Modeling-Trial-Cost-and-Timelines-to-Maximize-Decentralized-Clinical-Trial-ROI
ROI Calculator
Calculate your savings today! 
Calculate your Virtual Site ROI with a Science 37 Expert
Schedule time with a Science 37 expert and receive personalized results on how decentralized solutions can: Accelerate timelines Save opportunity costs Increase patient enrollment…
Learn More
/Resources/calculate-your-trial-savings-science-37-expert
Published Paper
Applied Clinical Trials
Evaluating the Use of Backup Solutions for ePRO Systems
A retrospective examination of the effectiveness, usability, and challenges with web-based electronic clinical outcome assessment (eCOA) backups.
Read More
https://www.appliedclinicaltrialsonline.com/view/evaluating-the-use-of-backup-solutions-for-epro-systems
Report
Patient accessing teleheatlh in a decentralized clinical trial
How Decentralized and Hybrid Trials are Impacting Clinical Research
Science 37’s 2nd Annual The Future of Clinical Trials Survey shares how the acceleration and adoption of decentralized clinical trials will reshape the research landscape in 2023.…
Read Now
/decentralized-clinical-trials-trends-report-2022
White Paper
Diversity in Clinical Trials Whitepaper
How to Meet the FDA Diversity Action Plan Guidance
The pending FDA Guideline’s intention is clear—pharma companies must plan, report and collaborate to improve diverse representation in clinical trials. Most sponsors have assessed…
Read Now
S37_WhitePaper_Diversity_July2022_final2 (1).pdf
/Resources/how-meet-fda-diversity-action-plan-guidance
Insight Brief
Patient accessing decentralized clinical trials
Why Migraine and Other Headache Disorders Are a Good Fit for Decentralized Clinical Trials
Characterized by recurring episodes of moderate to severe headache, elevated sensitivity to sound and/or light and other unpleasant symptoms, migraines can often be debilitating for…
Read Now
Migraine Insight Brief (1).pdf
/Resources/why-migraine-headache-disorders-are-good-fit-decentralized-clinical-trials
Published Paper
Journal of Clinical Oncology
Decentralized Clinical Trials in Oncology: Are We Ready for a Virtual-First Paradigm?
In this paper, published in the Journal of Clinical Oncology, Dr. Shaalan Beg MD MS and team explore how decentralized clinical trial tools are poised to impact the oncology…
Read Now
https://ascopubs.org/doi/full/10.1200/JCO.22.00358
White Paper
An Executive Clinical Trial Playbook
An Executive Clinical Trial Playbook
How Decentralized and Hybrid Clinical Trials Accelerate Research and Enable Diversity   While no longer a new concept, decentralized clinical trials can be challenging to…
Read Now
/clinicaltrialplaybook
Insight Brief
Decentralized Clinical Trial Technology— How to Accelerate eCOA Implementation
Decentralized Clinical Trial Technology— How to Accelerate eCOA Implementation
The key benefits of decentralized clinical trials is the ability to enable faster implementation of trials, greater speed to go live, and accelerated timelines.   Electronic…
Learn More
S37_InsightBrief_eCOA_July2022_r3.pdf
/Resources/decentralized-clinical-trial-technology-how-accelerate-ecoa-implementation
Report
Download the Latest Oncology Research Report
How Decentralized Clinical Trials are Impacting Oncology Research
Clinical research is undergoing transformation across the board—but how will it impact oncology clinical trials? Science 37® has surveyed research executives at trial-sponsored…
Read Now
S37_ONC_FullReport_R8.pdf
/Resources/how-decentralized-clinical-trials-are-impacting-oncology-research
Insight Brief
Improve Long-Term Follow-Up Studies with DCT
Improve Long-Term Follow-Up Studies with Decentralized Clinical Trials
In his latest insight brief, Gordon Cummins shares how more agile and DCT approaches can optimize the delivery of long-term follow-up studies—improving and accelerating Real World…
Read now
RWE_InsightBrief_d05.pdf
/Resources/improve-long-term-follow-studies-dct
Factsheet
Accelerate Enrollment and Enable Diversity with The Science 37 Metasite™
Accelerate Enrollment and Enable Diversity with The Science 37 Metasite™
Traditional clinical trials exclude more than 90 percent of patients and providers because of geographic and access barriers. This leads to study delays, excessive costs, and…
Read now
S37_FactSheet_Metasite_Apr2022_r6.pdf
/Resources/accelerate-enrollment-and-enable-diversity-science-37-metasitetm
Factsheet
Mobile Nursing: A Global Mobile Healthcare Provider Network
Mobile Nursing: A Global Mobile Healthcare Network
The healthcare landscape has changed, and mobile healthcare is now an integral part of clinical research. Beyond nursing, mobile healthcare must deliver more – compassion,…
Read now
Mobile Nursing Fact Sheet - March 2022.pdf
/Resources/mobile-nursing-global-mobile-healthcare-network
Insight Brief
We have the capability to reach anyone, anywhere utilizing decentralized clinical trial techniques and more agile clinical trial designs.
Decentralization: An Ethical Obligation
For more than 60 years, the traditional clinical trial model has relied on a disparate network of independent investigator sites to find, enroll, and matriculate patients through a…
Read now
S37_InsightBrief_DecentralizationAnEthicalObligation_r3.pdf
/sites/default/files/2022-04/S37_InsightBrief_DecentralizationAnEthicalObligation_r3.pdf
Insight Brief
Clinical trials for rare diseases have always presented challenges. From investigator training to data collection, conducting clinical research for orphan disorders is mired with condition-specific challenges that slow development and place an enormous burden on patients wanting to participate in a potentially life-saving clinical trial.
Powering Rare Disease Research with Agile, Decentralized and Patient- Centric Approaches
Through the rapidly increasing trend of agile, patient-centric approaches, we can address the distinctive challenges for patients with rare diseases. Travel may be difficult. Many are…
Read now
Rare_Disease_Webinar_Insight_Brief_Web.pdf
/Resources/powering-rare-disease-research-agile-decentralized-and-patient-centric-approaches-0
Factsheet
Clinical trials for rare diseases have always presented challenges. From investigator training to data collection, conducting clinical research for orphan disorders is mired with condition-specific challenges that slow development and place an enormous burden on patients wanting to participate in a potentially life-saving clinical trial.
Making Rare Disease Research Easier for Patients, Easier for Everyone
Through the rapidly increasing trend of patient-centric research, we can address the distinctive challenges for patients with rare diseases. Travel may be difficult. Many are…
Read now
Rare_Disease_Fact_Sheet_Web.pdf
/Resources/making-rare-disease-research-easier-patients-easier-everyone
Report
How will decentralization impact CNS (central nervous system) clinical trials? Science 37 has surveyed research executives at trial-sponsoring organizations, uncovering pivotal insights on how clinical research trends are impacting the CNS space.
How Agile Clinical Trials are Impacting CNS Research
We know that clinical research is undergoing transformation across the board—but how will it impact CNS (central nervous system) clinical trials? Science 37® has surveyed research…
Read now
S37_CNS_FullReport_R9.pdf
/Resources/how-agile-clinical-trials-are-impacting-cns-research
Insight Brief
In this new insight brief, Science 37 CEO David Coman explains how agile and decentralized approaches actually offer sponsors more centralized command and oversight compared to traditional study design.
Centralize Clinical Trials with Decentralized Clinical Trials
As the industry adopts more agile and decentralized approaches, it has rallied around the term decentralized clinical trials and expanded its definition to include all mobile, remote,…
Read now
Insight Brief Centralize Clinical Trials.pdf
/sites/default/files/2022-05/Decentralized_Clinical_Trials_Insight_Brief_d01.pdf
Report
The Decentralized Clinical Trial Operating System
The Decentralized Clinical Trial Operating System
A requisite, technology-first platform with limitless configurations to enable clinical research.
Read now
/DCT-OS-Report
White Paper
Clinical Research in the COVID-19 Era: Methods for Continuity
Clinical Research in the COVID-19 Era: Methods for Continuity
Adjust ongoing trials and have the changes expeditiously reviewed by an accredited IRB.
Read now
/Covid-19
Factsheet
Empowering Diversity in Clinical Trials
Empowering Diversity in Clinical Trials
Diverse audiences want to participate in clinical trials but so often, are not asked, overlooked, or unable to access because of geographic barriers.  The Diversity in Clinical…
Read now
FACT-SHEET_Science-37-Diversity-and-Inclusion.pdf
/Resources/empowering-diversity-clinical-trials
White Paper
Navigating Clinical Trials in the Coronavirus Era
Navigating Clinical Trials in the Coronavirus Era
Explore approaches to mitigate risks to patient safety in ongoing clinical trials.
Read now
/Covid-19

© 2024  Science 37 | All Rights Reserved